Physician profile
Dennis E Sandler
NPI 1316245715
$657.64
in general payments reported to CMS, 2019-2025
11 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.64 · 2020: $217 · 2022: $146 · 2023: $28.97 · 2024: $44.72 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $112 · Food and Beverage: $84.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $112.35 |
| Food and Beverage | $84.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $244.65 | 2019-2020 | |
| Astellas Pharma US INC | $130.37 | 2024-2025 | Veozah |
| Abbvie INC. | $127.04 | 2022 | |
| Avion Pharmaceuticals | $34.06 | 2022-2023 | Balcoltra |
| Ibsa Pharma INC. | $23.83 | 2025 | Licart, Flector, Tirosint |
| Ascend Therapeutics US, LLC | $23.34 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.35 | 2019 | |
| Therapeuticsmd, INC. | $16.41 | 2019 | |
| Exact Sciences Corporation | $13.38 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $13.35 | 2024 | |
| Antares Pharma, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Sandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.